AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33214048 — intervention group
Group type: COMPARATOR
Intervention: SOR
Number of subjects: 106
Study 33288468 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-relaxing environments
Number of subjects: 180
Study 33288468 — intervention group
Group type: COMPARATOR
Intervention: Neutral environments
Number of subjects: 180
Study 33288468 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-stimulating environments
Number of subjects: 180
Study 33288468 — intervention group
Group type: COMPARATOR
Intervention: Altered states of consciousness and suggestibility
Number of subjects: 180
Study 33276768 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative cognitive behavioral therapy (CBT) - six individual sessions, two before and four after surgery.
Number of subjects: 0
Study 33276768 — intervention group
Group type: COMPARATOR
Intervention: Perioperative education plus progressive exercise program (control group).
Number of subjects: 0
Study 36231957 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-cash intervention (reminding patients of free T-shirts or Kiondos) and psychosocial support
Number of subjects: 0
Study 36231957 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without non-cash incentives)
Number of subjects: 0
Study 36231957 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall retention
Number of subjects: 0
Study 36231957 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality and lost to follow-up rates
Number of subjects: 0
Study 32931328 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine surveillance and contact tracing (surge testing) events
Number of subjects: 1434
Study 32931328 — intervention group
Group type: EXPERIMENTAL
Intervention: Surge testing events
Number of subjects: 1434
Study 32931328 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants aged 60 years or older
Number of subjects: 1434
Study 32931328 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeping arrangements
Number of subjects: 1434
Study 32920973 — intervention group
Group type: EXPERIMENTAL
Intervention: Refined rapeseed oil (RA) 50 g daily for 8 weeks
Number of subjects: 27
Study 32920973 — intervention group
Group type: COMPARATOR
Intervention: Refined olive oil (OL) 50 g daily for 8 weeks
Number of subjects: 27
Study 32037273 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/kg of methylprednisolone
Number of subjects: 29
Study 32037273 — intervention group
Group type: COMPARATOR
Intervention: Saline as placebo
Number of subjects: 29
Study 35074248 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum
Number of subjects: 156
Study 35074248 — intervention group
Group type: COMPARATOR
Intervention: Needle Fasciotomy (NF)
Number of subjects: 156
Study 34110885 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent group received monetary incentives for negative breathalyzer samples.
Number of subjects: 36
Study 34110885 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent group received matched incentives for samples independent of alcohol content.
Number of subjects: 36
Study 32444152 — intervention group
Group type: EXPERIMENTAL
Intervention: Land-walking (LW)
Number of subjects: 0
Study 32444152 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-walking (WW)
Number of subjects: 0
Study 32444152 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study 36268379 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 μg/kg/min remifentanil
Number of subjects: 110
Study 36268379 — intervention group
Group type: COMPARATOR
Intervention: 0.1 μg/kg/min remifentanil
Number of subjects: 110
Study 34711182 — intervention group
Group type: EXPERIMENTAL
Intervention: Online safety decision and planning intervention
Number of subjects: 0
Study 34711182 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety and empowerment strategies delivered via text only
Number of subjects: 0
Study 34711182 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of text and phone calls with trained advocates
Number of subjects: 0
Study 34711182 — intervention group
Group type: COMPARATOR
Intervention: Usual care control arm
Number of subjects: 0
Study 32841525 — intervention group
Group type: EXPERIMENTAL
Intervention: Actiponin (Gynostemma pentaphyllum extract)
Number of subjects: 0
Study 32841525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36208471 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth intervention (personalized psychoeducational session + 14-day eHealth intervention)
Number of subjects: 42
Study 33568118 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week psychosocial support program with oral health educational components
Number of subjects: 118
Study 33568118 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 118
Study 32988519 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan oligosaccharide (COS) supplementation at 200 mg/kg
Number of subjects: 108
Study 32988519 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet under normal temperature)
Number of subjects: 108
Study 32988519 — intervention group
Group type: COMPARATOR
Intervention: Heat stress group (HS) with basal diet under cycle heat stress
Number of subjects: 108
Study 34803023 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics prior to skin incision
Number of subjects: 63
Study 34803023 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics after umbilical cord clamping
Number of subjects: 63
Study 34803023 — intervention group
Group type: COMPARATOR
Intervention: Vaginal delivery (control)
Number of subjects: 63
Study 34463415 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 2477
Study 34463415 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 2477
Study 34463415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2477
Study 34463415 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (both doses)
Number of subjects: 2477
Study 33332233 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-fatigue PBM (Group 1)
Number of subjects: 35
Study 33332233 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-fatigue PBM (Group 2)
Number of subjects: 35
Study 33332233 — intervention group
Group type: COMPARATOR
Intervention: Placebo PBM
Number of subjects: 35
Study 34873781 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged intermittent theta burst stimulation (piTBS; N = 19)
Number of subjects: 61
Study 34873781 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS (N = 20)
Number of subjects: 61
Study 34873781 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (N = 22)
Number of subjects: 61
Study 32174361 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeuomorphic icons
Number of subjects: 48
Study 32174361 — intervention group
Group type: COMPARATOR
Intervention: Flat icons
Number of subjects: 48
Study 35993803 — intervention group
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Number of subjects: 2
Study 35993803 — intervention group
Group type: COMPARATOR
Intervention: Vorinostat
Number of subjects: 2
Study 34971270 — intervention group
Group type: COMPARATOR
Intervention: FMI (Facility-based intervention)
Number of subjects: 153
Study 34971270 — intervention group
Group type: COMPARATOR
Intervention: HMI (Home-based intervention)
Number of subjects: 153
Study 34971270 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153
Study 34927391 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive serum urate target of <0.20 mmoles/liter
Number of subjects: 104
Study 34927391 — intervention group
Group type: COMPARATOR
Intervention: Standard target of <0.30 mmoles/liter
Number of subjects: 104
Study 34927391 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive target group
Number of subjects: 104
Study 34927391 — intervention group
Group type: COMPARATOR
Intervention: Standard target group
Number of subjects: 104
Study 34927391 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 104
Study 34419564 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-based BMS-IG-IMRT
Number of subjects: 101
Study 34419564 — intervention group
Group type: COMPARATOR
Intervention: Standard IMRT
Number of subjects: 101
Study 34419564 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cohort (PET-BMS-IMRT and IMRT)
Number of subjects: 101
Study 32402585 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy high pasta (HP) diet
Number of subjects: 49
Study 32402585 — intervention group
Group type: COMPARATOR
Intervention: Low-energy low pasta (LP) diet
Number of subjects: 49
Study 35584623 — intervention group
Group type: EXPERIMENTAL
Intervention: Urolithin A (Mitopure)
Number of subjects: 0
Study 33245130 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dairy diet (<1 serving dairy/d)
Number of subjects: 65
Study 33245130 — intervention group
Group type: COMPARATOR
Intervention: Adequate-dairy diet (3-4 servings dairy/d)
Number of subjects: 65
Study 33245130 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (both diets)
Number of subjects: 65
Study 32600919 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib plus Capecitabine (lap-cap)
Number of subjects: 30
Study 32600919 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab plus Capecitabine (tras-cap)
Number of subjects: 30
Study 35736394 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 2727
Study 35736394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2727
Study 33245439 — intervention group
Group type: EXPERIMENTAL
Intervention: 25(OH) vitamin D levels (specifically SNP rs12785878)
Number of subjects: 20183
Study 33245439 — intervention group
Group type: COMPARATOR
Intervention: None (reverse analysis)
Number of subjects: 20183
Study 34963069 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner delivered relaxation massage
Number of subjects: 44
Study 34963069 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 44
Study 33801641 — intervention group
Group type: EXPERIMENTAL
Intervention: Red-fleshed apple
Number of subjects: 25
Study 33801641 — intervention group
Group type: COMPARATOR
Intervention: Placebo (white-fleshed apple)
Number of subjects: 25
Study 33373036 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day for six months
Number of subjects: 61
Study 33373036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 34415638 — intervention group
Group type: EXPERIMENTAL
Intervention: modified mindfulness‐based stress reduction (mMBSR), n = 120
Number of subjects: 246
Study 34415638 — intervention group
Group type: COMPARATOR
Intervention: waitlist control group, n = 123
Number of subjects: 246
Study 33641940 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage
Number of subjects: 142
Study 33641940 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 142
Study 32144165 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (DAPA) 10 mg
Number of subjects: 14
Study 32144165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 34220519 — intervention group
Group type: EXPERIMENTAL
Intervention: HOT-1010
Number of subjects: 84
Study 34220519 — intervention group
Group type: COMPARATOR
Intervention: Avastin®
Number of subjects: 84
Study 32229754 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg
Number of subjects: 140
Study 32229754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 34164999 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP)
Number of subjects: 200
Study 33091219 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic submucosal dissection
Number of subjects: 98
Study 33091219 — intervention group
Group type: COMPARATOR
Intervention: Transanal endoscopic microsurgery
Number of subjects: 98
Study 33025002 — intervention group
Group type: COMPARATOR
Intervention: Combined estrogens plus progestin
Number of subjects: 27347
Study 32883567 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg/day, n = 31)
Number of subjects: 51
Study 32883567 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (n = 18)
Number of subjects: 51
Study 33724356 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital admissions (HA)
Number of subjects: 1000
Study 33724356 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department presentations (ED)
Number of subjects: 1000
Study 33724356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of hospital admissions (HA)
Number of subjects: 1000
Study 33724356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of emergency department presentations (ED)
Number of subjects: 1000
Study 32444045 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet for 10 weeks
Number of subjects: 80
Study 32444045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study 35842614 — intervention group
Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED) with Mind the Gap (MTG)
Number of subjects: 0
Study 35842614 — intervention group
Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED) with Remaking Recess (RR)
Number of subjects: 0
Study 35842614 — intervention group
Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED) with Self-Determined Learning Model of Instruction (SDLMI)
Number of subjects: 0
Study 35842614 — intervention group
Group type: EXPERIMENTAL
Intervention: Using Novel Implementation Tools for Evidence-based intervention Delivery (UNITED)
Number of subjects: 0
Study 35842614 — intervention group
Group type: COMPARATOR
Intervention: Control group without UNITED
Number of subjects: 0
Study 34020345 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive therapy (Flunarizine) on standardized IS treatment
Number of subjects: 41
Study 32005332 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized anxiety-insomnia intervention
Number of subjects: 61
Study 32005332 — intervention group
Group type: COMPARATOR
Intervention: Physical health control condition
Number of subjects: 61
Study 33685898 — intervention group
Group type: EXPERIMENTAL
Intervention: Biapenem 250 mg
Number of subjects: 36
Study 33685898 — intervention group
Group type: EXPERIMENTAL
Intervention: Biapenem 1250 mg
Number of subjects: 36
Study 33685898 — intervention group
Group type: EXPERIMENTAL
Intervention: Biapenem 1000 mg
Number of subjects: 36
Study 32525222 — intervention group
Group type: EXPERIMENTAL
Intervention: Active bilateral anodal transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC) for 10 days
Number of subjects: 33
Study 32525222 — intervention group
Group type: COMPARATOR
Intervention: Sham bilateral anodal transcranial direct current stimulation (tDCS)
Number of subjects: 33
Study 32412181 — intervention group
Group type: EXPERIMENTAL
Intervention: Live lecture (45 min)
Number of subjects: 45
Study 32412181 — intervention group
Group type: COMPARATOR
Intervention: Videos (45 min)
Number of subjects: 45
Study 32412181 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (live lecture and videos)
Number of subjects: 45
Study 32412181 — intervention group
Group type: EXPERIMENTAL
Intervention: Photograph analysis
Number of subjects: 45
Study 35101133 — intervention group
Group type: EXPERIMENTAL
Intervention: SHARP + usual home care
Number of subjects: 60
Study 35101133 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 60
Study 32393616 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture for insomnia with short sleep duration
Number of subjects: 0
Study 32064652 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared PBM (830 nm and 55 mW/cm2) for 5 minutes
Number of subjects: 20
Study 32064652 — intervention group
Group type: EXPERIMENTAL
Intervention: Red light PBM (633 nm and 70 W/cm2) for 5 minutes
Number of subjects: 20
Study 32064652 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders (10 out of 20 participants) identified by thermal imaging
Number of subjects: 20
Study 32064652 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-responders
Number of subjects: 20
Study 35040231 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements
Number of subjects: 0
Study 35040231 — intervention group
Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 0
Study 35799121 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced adherence counselling and biofeedback (using urine tenofovir tests for biofeedback) and rapid PrEP collection
Number of subjects: 650
Study 35799121 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counseling and biofeedback plus rapid PrEP collection
Number of subjects: 650
Study 35799121 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 650
Study 35799121 — intervention group
Group type: COMPARATOR
Intervention: Community PrEP delivery with HIV self-testing
Number of subjects: 650
Study 32367561 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate periodontal therapy (oral hygiene instructions and single-visit scaling and root planing)
Number of subjects: 140
Study 32367561 — intervention group
Group type: COMPARATOR
Intervention: Delayed periodontal treatment (control group)
Number of subjects: 140
Study 34420834 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide 25 mg/day
Number of subjects: 335
Study 34420834 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide 50 mg/day (flexible dosing)
Number of subjects: 335
Study 34420834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study 33600189 — intervention group
Group type: EXPERIMENTAL
Intervention: l-homocysteine aptamer (randomized SELEX)
Number of subjects: 0
Study 33600189 — intervention group
Group type: EXPERIMENTAL
Intervention: l-homocysteine selection (redirected SELEX)
Number of subjects: 0
Study 33600189 — intervention group
Group type: EXPERIMENTAL
Intervention: original DNA library (original SELEX)
Number of subjects: 0
Study 33600189 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncated aptamer
Number of subjects: 0
Study 33600189 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiegelmer derived from truncated sequence
Number of subjects: 0
Study 36269355 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel brief motivational intervention (in-person discussion and up to 3 booster telephone calls)
Number of subjects: 344
Study 36269355 — intervention group
Group type: COMPARATOR
Intervention: Control group (brief advice)
Number of subjects: 344
Study 36269355 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel brief motivational intervention
Number of subjects: 344
Study 34508364 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed CPAP
Number of subjects: 46
Study 34508364 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto‐adjusting Pressure (APAP)
Number of subjects: 46
Study 34474590 — intervention group
Group type: EXPERIMENTAL
Intervention: Teprasiran (10 mg/kg single dose)
Number of subjects: 360
Study 34474590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 32980764 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric ropivacaine (9.5, 11, 12.5, 14, or 15.5 mg)
Number of subjects: 200
Study 35821400 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) programme for 2 weeks
Number of subjects: 50
Study 35821400 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cardiac rehabilitation)
Number of subjects: 50
Study 35801003 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 208188
Study 35862166 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D MOT training
Number of subjects: 31
Study 35862166 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 31
Study 33798028 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher trait mindfulness scores
Number of subjects: 70
Study 33798028 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait mindfulness
Number of subjects: 70
Study 32533949 — intervention group
Group type: EXPERIMENTAL
Intervention: OMDI 0.002%
Number of subjects: 190
Study 32533949 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 190
Study 34980198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (25 mg orally three times a day for seven days)
Number of subjects: 40
Study 34980198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical capsules, same dosage and duration)
Number of subjects: 40
Study 34980198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 40
Study 36342059 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness therapy (8-week face-to-face group program)
Number of subjects: 60
Study 34404324 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization (NM)
Number of subjects: 54
Study 34404324 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization through mirror therapy (MT)
Number of subjects: 54
Study 34404324 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization through action observation (AO) training
Number of subjects: 54
Study 34404324 — intervention group
Group type: COMPARATOR
Intervention: Classic rehabilitation program (mobility and strength) exercises
Number of subjects: 54
Study 32740192 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0
Study 32740192 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33421650 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital training (DGT)
Number of subjects: 336
Study 33421650 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital training combined with individualized coaching support (DGT+)
Number of subjects: 336
Study 33421650 — intervention group
Group type: COMPARATOR
Intervention: Conventional face-to-face training (F2F)
Number of subjects: 336
Study 616119841 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab plus PRP
Number of subjects: 125
Study 616119841 — intervention group
Group type: COMPARATOR
Intervention: PRP only
Number of subjects: 125
Study 32758384 — intervention group
Group type: EXPERIMENTAL
Intervention: early parenteral nutrition (early-PN)
Number of subjects: 786